Paraplegia

Stoke for Life Foundation and The U.S. Open Adaptive Surfing Championships, Announce World-Wide Tour

Retrieved on: 
Friday, March 15, 2024
ISA, Thought, Partnership, Life, Paraplegia, Human, Paralympic Games, University, Disability, Kiteboarding, Tourism

OCEANSIDE, Calif. , March 15, 2024 /PRNewswire-PRWeb/ -- Stoke for Life Foundation, in partnership with the Visit Oceanside and the Association of Adaptive Surfing Professionals is pleased to announce the upcoming dates for the 2024 Visit Oceanside Adaptive Surfing Professionals World Championship Tour, powered by The University of St. Augustine.

Key Points: 
  • OCEANSIDE, Calif. , March 15, 2024 /PRNewswire-PRWeb/ -- Stoke for Life Foundation , in partnership with the Visit Oceanside and the Association of Adaptive Surfing Professionals is pleased to announce the upcoming dates for the 2024 Visit Oceanside Adaptive Surfing Professionals World Championship Tour, powered by The University of St. Augustine .
  • "This is so much more than a competition," said Stoke for Life Foundation's founder, Charles Webb .
  • Webb, who is a world class adaptive surfer, founded Stoke for Life after a motorcycle accident left him a Paraplegic.
  • Stoke for life and the U.S Open ASC Powered by The University of St. Augustine is encouraging other adaptive surfers to sign up to compete.

Endospan Releases Early TRIOMPHE IDE Study Results at Society of Thoracic Surgeons

Retrieved on: 
Tuesday, January 30, 2024
Surgery, Medical Devices, Clinical Trials, Health Technology, Cardiology, Biotechnology, Health, General Health, Oncology, Multimedia, ICU, Surgeon, Mortality, Hypothermia, Trial of the century, Kidney, Disease, NEXUS, Society, Patient, Safety, Hospital, Paraplegia, IDE

As a notice of availability to educate potential referring physicians about the TRIOMPHE study, Endospan shared the 30-day results of the first 22 patients enrolled in the TRIOMPHE IDE study in a Late-Breaking presentation at the 60th Annual Meeting of the Society of Thoracic Surgeons in San Antonio, Texas this past weekend.

Key Points: 
  • As a notice of availability to educate potential referring physicians about the TRIOMPHE study, Endospan shared the 30-day results of the first 22 patients enrolled in the TRIOMPHE IDE study in a Late-Breaking presentation at the 60th Annual Meeting of the Society of Thoracic Surgeons in San Antonio, Texas this past weekend.
  • TRIOMPHE is a multi-arm, multi-center, non-randomized, prospective, clinical study to evaluate the safety and effectiveness of NEXUS® in treating thoracic aortic lesions involving the aortic arch.
  • “NEXUS is designed for total endovascular arch repair to address the specific challenges of the aortic arch anatomy,” said Kevin Mayberry, CEO.
  • “We are pleased to see that this early data aligns with the results achieved during the EU clinical study.

Getting People with Disabilities Back to Work

Retrieved on: 
Thursday, August 31, 2023
Shepherd Center, Workforce, U.S. Department of Labor, Office of Inspector General, Shepherd, U.S. Department of Commerce Office of Security, Disability, Workplace, Spinal cord, Stroke, PT, MBA, Rehabilitation, Multiple sclerosis, Pain, GPC, Patient, Brain, Genuine Parts Company, Paraplegia, United States Department of Labor, MHA, Nursing

ATLANTA, Aug. 31, 2023 /PRNewswire/ -- According to the U.S. Department of Labor's Office of Disability Employment Policy, people with disabilities participate in the U.S. labor force at a rate 44% lower than people who do not have disabilities – a statistic that, together, Genuine Parts Company (GPC) and Shepherd Center are working to change.

Key Points: 
  • Shepherd Center, Genuine Parts Company partner to help people with disabilities make their mark in the workplace.
  • Shepherd Center, Genuine Parts Company partner to help people with disabilities make their mark in the workplace.
  • GPC and Shepherd Center, both headquartered in Atlanta, Georgia, recently announced the establishment of the Genuine Parts Company Vocational Rehabilitation Program at Shepherd Center.
  • "Through their intense rehabilitation, Shepherd Center patients demonstrate resilience, focus, and commitment," says Paul Donahue, chairman and chief executive officer at Genuine Parts Company.

Schah Sedi und Schah Sedi Rechtsanwälte Named “Stern Best Law Firms 2023”

Retrieved on: 
Monday, August 14, 2023
Insurance, Sedi, Specialist, Accident, Paraplegia, Lawyer, Pain, Brain, Child, Injury, Real estate

Schah Sedi und Schah Sedi Rechtsanwälte was named as one of Stern’s Best Law Firms for 2023.

Key Points: 
  • Schah Sedi und Schah Sedi Rechtsanwälte was named as one of Stern’s Best Law Firms for 2023.
  • This is in recognition of the exceptional work that the Schah Sedi und Schah Sedi Rechtsanwälte is doing.
  • Schah Sedi und Schah Sedi Rechtsanwälte has received awards and press for being one of the best law firms in Germany for the past few years.
  • Schah Sedi und Schah Sedi Rechtsanwälte is consistently ranked as one of the best law firms for these kinds of cases, because of their proven track record of helping clients win excellent compensation.

One Call Celebrates the Strength and Determination of Injured Workers With the Launch of Injured to Empowered

Retrieved on: 
Wednesday, July 19, 2023
Learning, Heart, National Safety Month, Elbow, Life, Paraplegia, Safe, Attitude, OSHA, Amputation, Cooking, Major trauma, Love, Tetraplegia, Injury, Safety, Management, Insurance, Nursing

JACKSONVILLE, Fla., July 19, 2023 /PRNewswire/ -- One Call, the nation's leading care coordinator of ancillary services for the workers' compensation industry, today announced the launch of its Injured to Empowered™ program, an ongoing celebration of injured workers who have risen above their injuries.

Key Points: 
  • One Call, along with its partners, plays a vital role in these journeys by getting injured workers the care they need when they need it.
  • While we can't completely prevent these injuries from occurring, we can help injured workers strive for a quality life post-injury."
  • "Injured to Empowered reinforces our purpose-driven approach to workers' compensation," said One Call CEO Jay Krueger.
  • Watch Billy P's full story on the Injured to Empowered webpage, onecallcm.com/empowered , and visit often for additional success stories.

ATF Medical Names Abbi Akstulewicz Director of Payer Partnerships

Retrieved on: 
Monday, May 22, 2023
Insurance, Medical Devices, Medical Supplies, Human Resources, Finance, Professional Services, Health Insurance, Managed Care, Health, Volunteering, Partnership, Swift, Tetraplegia, Paraplegia, Nursing, Marketing, Culture, Rasmussen University, Multimedia, IRSG, Associate of Science in Nursing, PCW

Abbi Akstulewicz has joined ATF Medical in the newly created position of director of payer partnerships.

Key Points: 
  • Abbi Akstulewicz has joined ATF Medical in the newly created position of director of payer partnerships.
  • View the full release here: https://www.businesswire.com/news/home/20230522005069/en/
    Abbi Akstulewicz joins ATF Medical as director of payer partnerships.
  • “Abbi’s deep passion to serve injured workers combined with her desire for strong payer relationships make her a great fit for our culture here at ATF Medical,” Swift said.
  • In addition, she volunteers as the director of the Leopolis Booster Club, a community outreach program in Shawano, Wisconsin.

Neura Health Secures $8M in Financing to Support Go-To-Market Expansion to Employers and Health Plans

Retrieved on: 
Wednesday, May 17, 2023
Health, Apps, Applications, Technology, Telemedicine, Virtual Medicine, Neurology, Other Health, General Health, Presenteeism, Workforce, ER, Migraine, Partnership, Headache, Prevalence, Norwest Venture Partners, Paraplegia, Partner, Ginger, Absenteeism, DoorDash, Pear VC, Paratriathlon, Patient, Growth, ROI, Sleep, World Health Organization, Pharmaceutical industry, Health insurance, Neuroscience Research Australia

The funding will allow Neura to expand its go-to-market approach, moving beyond the consumer market to bring the company’s neurology care offering to the enterprise sector, with an initial focus on employers and health plans.

Key Points: 
  • The funding will allow Neura to expand its go-to-market approach, moving beyond the consumer market to bring the company’s neurology care offering to the enterprise sector, with an initial focus on employers and health plans.
  • Migraine is the second leading cause of global disability, with the World Health Organization considering chronic migraine to be more disabling than blindness or paraplegia.
  • “Despite the prevalence of headache disorders and migraine disease among employees, most employers aren’t equipped to support this part of their workforce.
  • To discuss Neura Health as a health benefit for your employees, visit the partner page.

Outlook on the Bionic Devices Global Market to 2027: Cochlear Implant Device Will Lead in Treatment Type - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 21, 2023
Medical Devices, Health, Hearing, Nerve, Medtronic, Hearing loss, Longevity, Diaphragm, Abbott, Hospital, Research, FDA, Implant failure, Investment, Growth, WHO, Paraplegia, Conditional sentence, Electronics, Assistive technology, Movement, Dental implant, Prevalence, Kool-Aid, Medical device, Health insurance, Exoskeleton, Bionics

According to our research findings, Worldwide Bionic Devices Market size was US$ 5.41 Billion in 2022.

Key Points: 
  • According to our research findings, Worldwide Bionic Devices Market size was US$ 5.41 Billion in 2022.
  • Based on treatment type, the global bionic devices market is divided into; Cochlear Implants, Exoskeletons, Bionic Cardiology, and Ventricular Assist Devices.
  • Based on technology, the global bionic devices market is categorized into; electronics and mechanical devices.
  • North America has the highest market due to the high prevalence of chronic diseases, rising healthcare expenditure, and acceptance of bionic devices.

Stand Up Therapeutics Signed with VectorBuilder for World's First Gene Therapy Supply for Paraplegia Patient

Retrieved on: 
Thursday, December 29, 2022
Motor neuron, Fibroblast, Paralysis, Patient, Brain, Injury, Health, Spinal stenosis, Stroke, Spinal cord, University, Therapy, Myocardial infarction, Stand Up, Parkinson's disease, GMP, Paraplegia, SCI, Vaccine, Medical device

SEOUL, South Korea, Dec. 29, 2022 /PRNewswire/ -- VectorBuilder is the world's largest supplier of customized vectors for viral and non-viral gene delivery, operating as a multinational corporation headquartered in Chicago, USA with offices in North America, Europe, China, Japan, Korea, Australia and Israel. Currently, more than 80,000 custom vectors are produced annually for numerous researchers around the world. VectorBuilder has GMP facilities for gene delivery systems, and supplies gene therapy products and delivery systems for thousands of institutions around the world and more than 50,000 customers, including all the leading pharmaceutical companies and major universities. We are supplying gene therapy products and delivery systems.

Key Points: 
  • Stand Up Therapeutics Co., Ltd, located in South Korea, is a gene therapy company for paralyzed patients with spinal cord injury.
  • Stand Up Therapeutics announced that it had signed an agreement with VectorBuilder Inc., a global leader in gene delivery solutions, to manufacture a GMP grade gene delivery system.
  • According to Stand Up Therapeutics, through this agreement, VectorBuilder will produce and supply gene therapy products designed by Stand Up Therapeutics in the future.
  • VectorBuilder's Chief Scientist Bruce Lahn said, "VectorBuilder is very interested in Stand Up Therapeutics's gene therapy for the treatment of paralysis at the global level.

ONWARD Awarded European Innovation Council Grant to Further Develop Brain-Computer Interface Technology; Company also Wins First Place in 2022 Brain-Computer Interface Awards

Retrieved on: 
Monday, November 21, 2022
Medical Devices, Health, Other Health, Research, Science, Biotechnology, University of California, San Francisco, EUR, CHUV, Euronext, Partnership, Materials Research Science and Engineering Centers, In the First Place, International, SCI, Interface (computing), Stanford University, Swiss Federal Institute of Aquatic Science and Technology, Loss of Sensation, Science, EIC, Quality of life, Spinal cord injury, Hyperreflexia, U.S. FDA, Pathfinder, EPFL, Swiss Federal Institute of Technology, Research, Spinal cord, Paralysis, Nature, Incontinence, Paraplegia, ARC, Record, European Innovation Council, Tetraplegia, Lausanne University Hospital, University, BCI, Movement, Infection, Hope, Health, NEMO, Brain–computer interface, Medical device, Pharmaceutical industry

Separately, ONWARD announced that it was the First Place Winner of the 2022 Brain-Computer Interface (BCI) Award .

Key Points: 
  • Separately, ONWARD announced that it was the First Place Winner of the 2022 Brain-Computer Interface (BCI) Award .
  • The award was granted to ONWARD and several research partners for their submission, Walking naturally after spinal cord injury using a brain-spine interface.
  • ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries.
  • You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.